Table 1. The clinical characteristics of CTNNB1 mutations.
| Pt ID | Mutation | Sex | Age | APA diameter (mm) | Side | AVS | NP59 | Number of nodules | Aldosterone (ng/dL) | Renin (ng/mL/hr) | Potassium mmol/dL | Categories before OP* | Categories after OP* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pt1 | S45F | F | 50 | 1.6 | L | lateralization | — | 1 | 28.9 | 0.31 | 3.7 | 1 | 1 |
| Pt2 | S45P | F | 54 | 1.0 | R | lateralization | — | 1 | 26.1 | 0.04 | 4.2 | 2 | 1 |
| Pt3 | S45P | F | 51 | 1.0 | L | lateralization | lateralization | 1 | 86.0 | 0.34 | 4.5 | 3 | 0 |
| Pt4 | S45P | F | 86 | 2.1 | R | lateralization | lateralization | 1 | 27.7 | 0.09 | 3.2 | 3 | 2 |
| Pt5 | S45P | M | 62 | 3.0 | R | — | lateralization | 1 | 40.5 | 0.27 | 3.7 | 3 | 3 |
| Pt6 | S45P | F | 58 | 1.2 | L | lateralization | lateralization | 1 | 195.8 | 0.24 | 3.4 | 3 | 2 |
| Pt7 | S45F | F | 62 | 2.7 | R | lateralization | — | 2 | 22.1 | 0.66 | 4.1 | 1 | 1 |
| Pt8 | S45F | M | 67 | 4.3 | R | — | lateralization | 1 | 24.8 | 0.35 | 4.0 | 1 | 1 |
*Categories of antihypertensive drugs.
Abbreviations: APA, aldosterone-producing adenoma; AVS, adrenal venous sampling; F, female,; M, male; L, left, OP, operation; Pt, patietns; R, right. NP-59 (SPECT/CT), I131–6b-iodomethyl-19-norcholesterol/SPECT/CT.